OBJECTIVE: To determine the relevance of the hormonal profile of patients with high grade prostatic intraepithelial neoplasia (HGPIN) and its relationship to prostate cancer (PCa) in rebiopsy.
PATIENTS AND METHODS: We prospectively analysed 82 consecutive patients with a diagnosis of HGPIN without PCa in a prostate biopsy between September 2007 and December 2009. Of these 82 patients, 45 underwent rebiopsy and their hormonal profile was determined (testosterone and sex hormone-binding globulin [SHBG]) as part of our clinical protocol. Patient age, PSA level, prostate volume, PSA density, testosterone, free testosterone, bioavailable testosterone and SHBG were recorded prospectively. A comparative study between those patients with a positive rebiopsy and those with a negative rebiopsy was performed.
RESULTS: We found that free testosterone (P= 0.04), bioavailable testosterone (P= 0.04) and SHBG (P= 0.02) were significantly associated with a positive rebiopsy. Other variables such as age (P= 0.745), PSA level (P= 0.630), prostate volume (P= 0.690), PSA density (P= 0.950), testosterone (P= 0.981) and prostatic intraepithelial neoplasia multifocality (P= 0.777) were not associated with the presence of adenocarcinoma in the rebiopsy.
CONCLUSIONS: Patients with adenocarcinoma of the prostate after a diagnosis of HGPIN have higher SHBG levels and lower calculated free testosterone levels than patients with a negative rebiopsy. Testosterone levels might be a useful indication for rebiopsy after HGPIN diagnosis.
Written by:
García-Cruz E, Piqueras M, Ribal MJ, Huguet J, Serapiao R, Peri L, Izquierdo L, Alcaraz A. Are you the author?
Urology Department, Hospital Clinic de Barcelona, Barcelona, Spain.
Reference: BJU Int. 2012 Jan 18. Epub ahead of print.
doi: 10.1111/j.1464-410X.2011.10876.x
PubMed Abstract
PMID: 22257176
UroToday.com Prostate Cancer Section